CME
59
4
HIG
54
-8
COST
53
2
UNP
50
2
KIM
50
13
CNX
48
4
ADT
55
5
NDAQ
57
2
MAS
34
-4
MS
61
2
EXPE
54
-2
PNC
59
3
EFX
30
3
HPQ
37
6
AIV
34
4
GM
57
-6
ACN
22
6
FITB
65
2
ISRG
55
-2
TDC
63
3
CME
59
4
HIG
54
-8
COST
53
2
UNP
50
2
KIM
50
13
CNX
48
4
ADT
55
5
NDAQ
57
2
MAS
34
-4
MS
61
2
EXPE
54
-2
PNC
59
3
EFX
30
3
HPQ
37
6
AIV
34
4
GM
57
-6
ACN
22
6
FITB
65
2
ISRG
55
-2
TDC
63
3
Financhill
Back

Cyclerion Therapeutics, Inc. Vs. Charles River Laboratories International, Inc. Industry Stock Comparison

Buy
53

CYCN
Cyclerion Therapeutics, Inc.

Last Price:
$6.12
Seasonality Move:
-2.58%
Buy
59

CRL
Charles River Laboratories International, Inc.

Last Price:
$173.71
Seasonality Move:
5.93%
Buy
53
Cyclerion Therapeutics, Inc. (CYCN) is a Buy

Is Cyclerion Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cyclerion Therapeutics, Inc. [CYCN] share price is $6.15. The Score for CYCN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • CYCN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Charles River Laboratories International, Inc. (CRL) is a Buy

Is Charles River Laboratories International, Inc. a Buy, Sell or Hold?

  • The current Charles River Laboratories International, Inc. [CRL] share price is $173.89. The Score for CRL is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CYCN Stock Price Chart

What is Cyclerion Therapeutics, Inc.'s stock price today?

  • The Cyclerion Therapeutics, Inc. share price today is $6.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYCN is experiencing slight buying pressure.

CRL Stock Price Chart

What is Charles River Laboratories International, Inc.'s stock price today?

  • The Charles River Laboratories International, Inc. share price today is $173.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRL is experiencing slight selling pressure.

CYCN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.01 Buy
Relative Strength Index (14 RSI): 91.18 Buy
Chaikin Money Flow: 4700262 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.56 - 3.16) Buy
Bollinger Bands (100): (0.86 - 2.24) Buy

CRL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 55.9 Buy
Chaikin Money Flow: -231651 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (155.99 - 175.79) Buy
Bollinger Bands (100): (162.95 - 206.19) Sell

CYCN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.73 Buy
20-day SMA: 1.98 Buy
50-day SMA: 1.58 Buy
200-day SMA: 2.07 Buy
8-day EMA: 3.37 Buy
20-day EMA: 2.08 Buy
50-day EMA: 1.09 Buy
200-day EMA: 0.32 Buy

CRL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 166.3 Buy
20-day SMA: 162.68 Buy
50-day SMA: 176.73 Sell
200-day SMA: 173.85 Buy
8-day EMA: 167.48 Buy
20-day EMA: 166.01 Buy
50-day EMA: 173.44 Buy
200-day EMA: 175.99 Sell

Cyclerion Therapeutics, Inc. Earnings Growth & CYCN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Charles River Laboratories International, Inc. Earnings Growth & CRL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.76 per share, a decrease next quarter of $0.47 per share, an increase this year of $0.87 per share, and an increase next year of $1.22 per share.

Cyclerion Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Charles River Laboratories International, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):